Stevioside inhibits experimental fibrosis by downregulating profibrotic Smad pathways and blocking HSC activation

Liver cirrhosis is associated with increased morbidity and mortality with important health and social consequences; however, an effective treatment has not been found yet. Previous reports have shown some beneficial effects of stevioside (SVT) in different diseases, but the ability of SVT to inhibit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Basic Clin Pharmacol Toxicol
Hauptverfasser: Casas-Grajales, Sael, Alvarez-Suarez, Diana, Ramos-Tovar, Erika, Buendía-Montaño, Laura Dayana, Reyes-Gordillo, Karina, Camacho, Javier, Tsutsumi, Víctor, Lakshman, M. Raj, Muriel, Pablo
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2019
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6513700/
https://ncbi.nlm.nih.gov/pubmed/30561898
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcpt.13194
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge